AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 15 filers reported holding AMBRX BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,611,000 | -59.2% | 1,491,832 | 0.0% | 0.07% | -55.3% |
| Q2 2022 | $3,953,000 | -35.7% | 1,491,832 | 0.0% | 0.15% | -20.2% |
| Q1 2022 | $6,146,000 | -35.7% | 1,491,832 | +41.0% | 0.19% | +1.6% |
| Q4 2021 | $9,551,000 | -58.3% | 1,057,735 | -9.6% | 0.18% | -46.1% |
| Q2 2021 | $22,923,000 | – | 1,169,529 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 11,304,573 | $100,836,791 | 27.58% |
| COMMODORE CAPITAL LP | 4,803,447 | $42,846,747 | 6.52% |
| VR Adviser, LLC | 3,298,577 | $29,423,307 | 5.74% |
| Cormorant Asset Management, LP | 8,500,000 | $75,820 | 4.99% |
| Ghost Tree Capital, LLC | 250,000 | $2,230,000 | 0.66% |
| TOMS Capital Investment Management LP | 1,000,000 | $8,920,000 | 0.55% |
| Artal Group S.A. | 702,291 | $6,264 | 0.37% |
| Fosun International Ltd | 249,190 | $2,222,775 | 0.21% |
| D. E. Shaw & Co., Inc. | 3,933,552 | $35,087,284 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 361,000 | $3,220,120 | 0.02% |